Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia

MeSH terms

• Adult
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects*
• Benzenesulfonates / administration & dosage
• Benzenesulfonates / adverse effects*
• Hematopoietic Stem Cell Transplantation*
• Humans
• Leukemia, Myeloid, Acute
• Male
• Niacinamide / analogs & derivatives
• Phenylurea Compounds
• Polycythemia / chemically induced*
• Polycythemia / drug therapy
• Pyridines / administration & dosage
• Pyridines / adverse effects*
• Sorafenib
• Transplantation, Homologous
• Unrelated Donors*